Red Orbit (Free subscription) | 10/13/2008
Medicis Aesthetics, a wholly owned subsidiary of Medicis Pharmaceutical, has announced that the FDA has approved its premarket approval application supplement, based on clinical data which highlights Restylane's duration effect up to 18 months in 97% of patients with repeated treatment.
The Earth Times Online Newspaper (Free subscription) | 10/11/2008
SAN DIEGO - Coughlin Stoia Geller Rudman & Robbins LLP (“Coughlin Stoia”) (
Market Wire - Class Action (Free subscription) | 10/08/2008
OKLAHOMA CITY, OK (MARKET WIRE) On October 3, 2008, a class action lawsuit was filed in the United States District Court for the District of Arizona against Medicis Pharmaceutical Corp. (NYSE: MRX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations...
Market Wire - Class Action (Free subscription) | 10/06/2008
BALA CYNWYD, PA (MARKET WIRE) Law offices of Brodsky & Smith, LLC announces that a class action lawsuit has been filed on behalf of all persons who purchased the common stock of Medicis Pharmaceutical Corp. ("Medicis" or the "Company") (NYSE: MRX) between October 30, 2003 and September 24, 2008 (the "Class Period"). The class action lawsuit was filed in the United States District Court for the District...
The Earth Times Online Newspaper (Free subscription) | 10/04/2008
NEW ORLEANS, LA -- 10/04/08 -- Kahn Gauthier Swick, LLC ("KGS") announces that a securities class action lawsuit was filed in the United States District Court for the District of Arizona, on behalf of purchasers of the stock of Medicis Pharmaceutic..
The Earth Times Online Newspaper (Free subscription) | 10/04/2008
NEW YORK, NY -- 10/03/08 -- The Rosen Law Firm today announced that it has filed a class action lawsuit on behalf of all purchasers of Medicis Pharmaceutical Corp. ("Medicis") (NYSE: MRX) stock during the period from October 30, 2003 through Septe..
Market Wire - Class Action (Free subscription) | 10/04/2008
NEW YORK, NY (MARKET WIRE) The Rosen Law Firm today announced that it has filed a class action lawsuit on behalf of all purchasers of Medicis Pharmaceutical Corp. ("Medicis") (NYSE: MRX) stock during the period from October 30, 2003 through September 24, 2008 (the "Class Period").
24/7 Wall St. (Free subscription) | 09/24/2008
Pilgrim's Pride (PPC) Company says it will have lay-offs. Drops to $6.06 from 52-week high of $35.98. Medicis Pharmaceutical (MRX) Firm says it will restate... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
The Industry Standard (Free subscription) | 09/24/2008
Medicis Pharmaceutical Corp. said Wednesday it expects to restate its results for a six-year period because of errors in the way it calculated the cost of returned products. The restatement primarily affects the period starting July 1, 2002, and ending December 31, 2005, but will continue through the six months ended June 30, 2008. The company did not offer an estimate of how much revenue might be...
Patent Baristas (Free subscription) | 09/12/2008
In Prasco v. Medicis Pharmaceutical (07-1524), Prasco tried to get a declaratory judgment that one of its products did not infringe various patents owned by Medicis Pharmaceutical Corp. and Imaginative Research Associates. The district court dismissed the action for lack of jurisdiction, concluding that Prasco’s complaint failed to establish a case or controversy under Article [...]
Patently-O: Patent Law Blog (Free subscription) | 08/19/2008
Prasco LLC v Medicis Pharmaceutical Corp. and Imaginative Research (Fed. Cir. 2008) Imaginative Research owns of several patents covering a prescription strength benzoyl peroxide wash. Medicis is the exclusive licensee and sells the product under the brand name TRIAZ. The...
Seeking Alpha (Free subscription) | 08/19/2008
Medicis Pharmaceutical Corporation (MRX) Q2 2008 Earnings Call Transcript Complete Story »
Patent Docs (Free subscription) | 08/19/2008
By Kevin E. Noonan -- The Supreme Court has spent the past few years issuing decision after decision circumscribing the Federal Circuit's Congressionally-mandated authority over U.S. patent law, pursuant to its plenary powers under Article III of the Constitution. Among these decisions (including KSR Int'l Co. v. Teleflex Inc., eBay Inc. v. MercExchange, LLC, Quanta Computer, Inc. v. LG Electronics,...
The Business Journal of Phoenix (Free subscription) | 08/06/2008
Revenue was up but profits declined in the second quarter at Medicis Pharmaceutical Corp.
The Business Journal of Phoenix (Free subscription) | 07/09/2008
Scottsdale-based Medicis Pharmaceutical Corp. (NYSE: MRS) announced that Tuesday that it has moved into its new 150,000-square-foot corporate headquarters at Riverwalk in Scottsdale. (MRS)
